Equillium, Inc. (EQ) Social Stream



Equillium, Inc. (EQ): $2.31

0.25 (+12.14%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

B

Add EQ to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#32 of 365

in industry

Featured Post From StockTwits About EQ

$EQ New Press Release:

Equillium to Present at the BTIG Virtual Biotechnology Conference

Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders, announced today that it will present at the BTIG Virtual Biotechnology Conference, taking place August 9 & 10, 2021. Bruce Steel, Equillium’s chief executive officer, and Dolca Thomas, M.D., Equillium’s executive vice president of research and development and chief medical officer, will provide a high-level overview of the Company’s clinical focus befo (...)

https://wchr.one/104093
WebChronicleToday, published August 5, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!